In this study, both genetic ablation and pharmacological inhibition of cathepsin S with a compound of undisclosed structure has been demonstrated to result in suppression of the metastatic spread of human MDA-MB-231 breast cancer cells to the brain in a mouse model. Here, CTSS is linked to breast cancer.